Goat Anti-Human IgG H&L (FITC)
Be the first to review this product! Submit a review
|
(13 Publications)
Goat Anti-Human IgG H&L (FITC) is a secondary antibody with a maximum absorption wavelength of 495nm and a maximum emission wavelength of 519nm. Ideal for fluorescent cell and tissue imaging. Suitable for Western blot, IHC, ICC/IF, Flow Cytometry, ELISA and more.
View Alternative Names
Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2
- WB
Supplier Data
Western blot - Goat Anti-Human IgG H&L (FITC) (AB6854)
Western blot analysis of ab6854 used as a secondary antibody at 1/1000 dilution for 60 min at RT.
All lanes:
Human IgG at 50 ng
Secondary
All lanes:
Western blot - Goat Anti-Human IgG H&L (FITC) (ab6854) at 1/1000 dilution
false
- Dot
Supplier Data
Dot Blot - Goat Anti-Human IgG H&L (FITC) (AB6854)
Dot blot analysis of ab6854.
Reactivity data
Product details
This antibody reacts with the heavy and light chains of Human IgG
Fluorochrome chart- a complete quick and easy guide to help you select the most appropriate fluorochromes for your next experiment.
When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Target data
Additional targets
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Journal for immunotherapy of cancer 12: PubMed39357981
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell discovery 10:99 PubMed39349449
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 5:101590 PubMed38843844
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 27:254 PubMed38682116
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of dental sciences 18:1008-1015 PubMed37404619
2023
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 12:1797-1813 PubMed35945910
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 18:1363-1380 PubMed35280694
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 21:400 PubMed33777223
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of infectious diseases 223:1313-1321 PubMed33605423
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 11:606967 PubMed33603676
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com